Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of SFN Group, Inc. (NYSE: SFN) arising from its proposed acquisition by Randstad Holding NV, a Netherlands-based HR company. Under the acquisition agreement, Randstad will commence a tender offer for all shares of SFN for $14 per share. The transaction is expected to close in September 2011, subject to customary closing conditions including regulatory approvals and the tender of at least 50% of SFN’s outstanding shares. Weiss & Lurie is investigating whether SFN’s Board acted in the best interests of its shareholders in approving the acquisition and whether the Board properly sought to maximize shareholder value. Notably, SFN stock traded at a high of $15.39 as recently as April 6, 2011. Several analysts have set the price target for SFN stock above $14 per share, with a high target of $17 per share. If you own SFN shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Julia J. Sun either by email at firstname.lastname@example.org or by telephone at (888) 593-4771. Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/. Attorney Advertising. Past results do not guarantee a similar outcome.